GB1290795A - - Google Patents
Info
- Publication number
- GB1290795A GB1290795A GB1290795DA GB1290795A GB 1290795 A GB1290795 A GB 1290795A GB 1290795D A GB1290795D A GB 1290795DA GB 1290795 A GB1290795 A GB 1290795A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkoxy
- alkyl
- radical
- hydrogen
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000003545 alkoxy group Chemical group 0.000 abstract 6
- 239000007788 liquid Substances 0.000 abstract 3
- -1 phenoxy, nitrophenoxy Chemical group 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 210000002027 skeletal muscle Anatomy 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000006583 (C1-C3) haloalkyl group Chemical group 0.000 abstract 1
- 125000006648 (C1-C8) haloalkyl group Chemical group 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- BLNWTAHYTCHDJH-UHFFFAOYSA-O hydroxy(oxo)azanium Chemical compound O[NH+]=O BLNWTAHYTCHDJH-UHFFFAOYSA-O 0.000 abstract 1
- 125000005113 hydroxyalkoxy group Chemical group 0.000 abstract 1
- 150000002475 indoles Chemical class 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000008016 pharmaceutical coating Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 125000006684 polyhaloalkyl group Polymers 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical class CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 abstract 1
- 235000012431 wafers Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA73876 | 1970-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1290795A true GB1290795A (enrdf_load_stackoverflow) | 1972-09-27 |
Family
ID=4086281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1290795D Expired GB1290795A (enrdf_load_stackoverflow) | 1970-02-03 | 1970-12-02 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3689657A (enrdf_load_stackoverflow) |
| BE (1) | BE759744A (enrdf_load_stackoverflow) |
| CA (1) | CA957281A (enrdf_load_stackoverflow) |
| FR (1) | FR2081480B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1290795A (enrdf_load_stackoverflow) |
| IL (1) | IL35772A (enrdf_load_stackoverflow) |
| NL (1) | NL7017489A (enrdf_load_stackoverflow) |
| ZA (1) | ZA708144B (enrdf_load_stackoverflow) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050203166A1 (en) * | 2000-06-30 | 2005-09-15 | Cancer Research Technology Limited | Indole-3-acetic acid derivatives |
| GB0016162D0 (en) * | 2000-06-30 | 2000-08-23 | Cancer Res Campaign Tech | Indole-3-acetic acid derivatives |
| ES2365847T3 (es) | 2003-10-03 | 2011-10-11 | Veijlen N.V. | Uso de derivados del ácido indolacético que aumentan la concentración sérica de igf-1 para la preparación de una composición terapéutica para el tratamiento de diversas enfermedades. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3322786A (en) * | 1965-10-07 | 1967-05-30 | Merck & Co Inc | 3-indolyl aliphatic acids |
| NL6702635A (enrdf_load_stackoverflow) * | 1966-03-04 | 1967-09-05 |
-
1970
- 1970-02-03 CA CA073,876A patent/CA957281A/en not_active Expired
- 1970-11-23 US US92299A patent/US3689657A/en not_active Expired - Lifetime
- 1970-11-30 NL NL7017489A patent/NL7017489A/xx unknown
- 1970-12-02 GB GB1290795D patent/GB1290795A/en not_active Expired
- 1970-12-02 ZA ZA708144A patent/ZA708144B/xx unknown
- 1970-12-02 IL IL35772A patent/IL35772A/xx unknown
- 1970-12-02 FR FR7043349A patent/FR2081480B1/fr not_active Expired
- 1970-12-02 BE BE759744D patent/BE759744A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL35772A0 (en) | 1971-02-25 |
| FR2081480A1 (enrdf_load_stackoverflow) | 1971-12-03 |
| IL35772A (en) | 1974-06-30 |
| CA957281A (en) | 1974-11-05 |
| ZA708144B (en) | 1972-07-26 |
| US3689657A (en) | 1972-09-05 |
| FR2081480B1 (enrdf_load_stackoverflow) | 1974-08-30 |
| NL7017489A (enrdf_load_stackoverflow) | 1971-08-05 |
| DE2061985A1 (de) | 1971-08-12 |
| BE759744A (fr) | 1971-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ208254A (en) | R-(-)- and s-(+)-4-(3-amino-2-hydroxypropoxy)-carbazoles, stereospecific preparations therefor, and pharmaceutical compositions | |
| KR910004582A (ko) | 티아졸 유도체, 이의 제조방법 및 이를 함유하는 약학조성물 | |
| ES8306160A1 (es) | "procedimiento para preparar un nuevo compuesto de cefem". | |
| FI952014A0 (fi) | Uusia bisyklisiä merkaptoasetyyliamidilaktaamijohdannaisia, jotka ovat hyödyllisiä enkefalinaasin ja ACE:n inhibiittoreina | |
| GB1418822A (en) | Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof | |
| GB1327312A (en) | Hererocyclic compounds | |
| KR900004658A (ko) | 이치환 벤질아민, 그의 제조방법, 약제로서의 그의 용도 및 그의 합성 약제 | |
| ES8502099A1 (es) | Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina. | |
| ES8609225A1 (es) | Un procedimiento para preparar un derivado de semicarbazida | |
| ES8300774A1 (es) | Un procedimiento para preparar nuevos compuestos de cefem | |
| GB1155936A (en) | Novel Sulphonamides and a Process for the Manufacture thereof | |
| GB1290795A (enrdf_load_stackoverflow) | ||
| ES8401068A1 (es) | Procedimiento para la preparacion de derivados de corinanteina, asi como de sus sales de adicion acida fisiologicamente inocuas. | |
| GB1527543A (en) | Basically substituted xanthine derivatives | |
| KR910009649A (ko) | 테트라히드로나프탈렌 유도체 및 이의 제조방법 | |
| ES8500953A1 (es) | Procedimiento para preparar derivados de tieno-tiazol | |
| GB1268956A (en) | Derivatives of 2-(halophenoxy or halophenylthio) alkanamides and their preparation | |
| KR850000455A (ko) | 세팔로스포린 에스테르 유도체의 제조방법 | |
| GB1055221A (en) | Pyridobenzoxazepine derivatives | |
| GB1511736A (en) | Amidino-hydrazone derivatives of benzocycloalkanones | |
| ES8405020A1 (es) | Un procedimiento para la preparacion de derivados de fosfolipidos. | |
| ES8501382A1 (es) | Procedimiento para la preparacion de derivados de acido fenilacetico. | |
| KR910009718A (ko) | 프라디미신 유도체 | |
| DE69619540D1 (de) | Arzneimittel enthaltend blutplättchenaggregationsinhibitoren | |
| KR850002258A (ko) | 디아진-에테닐 페닐옥삼산의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |